Literature DB >> 23662287

Nonmedical use of prescription opioids: what is the real problem?

Mary Lynch.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23662287      PMCID： PMC3718054          DOI： 10.1155/2013/824914

Source DB:  PubMed          Journal:  Pain Res Manag        ISSN： 1203-6765            Impact factor:   3.037


× No keyword cloud information.
  9 in total

1.  Motives, diversion and routes of administration associated with nonmedical use of prescription opioids.

Authors:  Sean Esteban McCabe; James A Cranford; Carol J Boyd; Christian J Teter
Journal:  Addict Behav       Date:  2006-07-13       Impact factor: 3.913

2.  Adolescents' motivations to abuse prescription medications.

Authors:  Carol J Boyd; Sean Esteban McCabe; James A Cranford; Amy Young
Journal:  Pediatrics       Date:  2006-12       Impact factor: 7.124

3.  Prescribing of opioid analgesics and related mortality before and after the introduction of long-acting oxycodone.

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Marco L A Sivilotti; Alex Kopp; Omar Qureshi; David N Juurlink
Journal:  CMAJ       Date:  2009-12-07       Impact factor: 8.262

4.  The need for a Canadian pain strategy.

Authors:  Mary E Lynch
Journal:  Pain Res Manag       Date:  2011 Mar-Apr       Impact factor: 3.037

5.  Use and nonmedical use of prescription opioid analgesics in the general population of Canada and correlations with dispensing levels in 2009.

Authors:  Kevin D Shield; Wayne Jones; Jürgen Rehm; Benedikt Fischer
Journal:  Pain Res Manag       Date:  2013 Mar-Apr       Impact factor: 3.037

6.  The prevalence of chronic pain and pain-related interference in the Canadian population from 1994 to 2008.

Authors:  M L Reitsma; J E Tranmer; D M Buchanan; E G Vandenkerkhof
Journal:  Chronic Dis Inj Can       Date:  2011-09

7.  Clustering of opioid prescribing and opioid-related mortality among family physicians in Ontario.

Authors:  Irfan A Dhalla; Muhammad M Mamdani; Tara Gomes; David N Juurlink
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

8.  Motives for nonmedical use of prescription opioids among high school seniors in the United States: self-treatment and beyond.

Authors:  Sean Esteban McCabe; Carol J Boyd; James A Cranford; Christian J Teter
Journal:  Arch Pediatr Adolesc Med       Date:  2009-08

9.  Trends in opioid use and dosing among socio-economically disadvantaged patients.

Authors:  Tara Gomes; David N Juurlink; Irfan A Dhalla; Angela Mailis-Gagnon; J Michael Paterson; Muhammad M Mamdani
Journal:  Open Med       Date:  2011-01-25
  9 in total
  5 in total

1.  Coupling Genetic Addiction Risk Score (GARS) with Electrotherapy: Fighting Iatrogenic Opioid Dependence.

Authors:  Kenneth Blum; Marlene Oscar-Berman; Nicholas Dinubile; John Giordano; Eric R Braverman; Courtney E Truesdell; Debmalya Barh; Rajendra Badgaiyan
Journal:  J Addict Res Ther       Date:  2013-10-31

2.  Canadian Orofacial Pain Team workshop report on the global year against orofacial pain.

Authors:  Gilles J Lavigne; Barry J Sessle
Journal:  Pain Res Manag       Date:  2014-12-18       Impact factor: 3.037

3.  Association Between Prescription Opioid Therapy for Noncancer Pain and Hepatitis C Virus Seroconversion.

Authors:  James Wilton; Stanley Wong; Roy Purssell; Younathan Abdia; Mei Chong; Mohammad Ehsanul Karim; Aaron MacInnes; Sofia R Bartlett; Rob F Balshaw; Tara Gomes; Amanda Yu; Maria Alvarez; Richard C Dart; Mel Krajden; Jane A Buxton; Naveed Z Janjua
Journal:  JAMA Netw Open       Date:  2022-01-04

4.  Prescription opioid treatment for non-cancer pain and initiation of injection drug use: large retrospective cohort study.

Authors:  James Wilton; Younathan Abdia; Mei Chong; Mohammad Ehsanul Karim; Stanley Wong; Aaron MacInnes; Rob Balshaw; Bin Zhao; Tara Gomes; Amanda Yu; Maria Alvarez; Richard C Dart; Mel Krajden; Jane A Buxton; Naveed Z Janjua; Roy Purssell
Journal:  BMJ       Date:  2021-11-18

5.  High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.

Authors:  Mark Moran; Kenneth Blum; Jessica Valdez Ponce; Lisa Lott; Marjorie C Gondré-Lewis; Sampada Badgaiyan; Raymond Brewer; B William Downs; Philip Fynman; Alexander Weingarten; Jean Lud Cadet; David E Smith; David Baron; Panayotis K Thanos; Edward J Modestino; Rajendra D Badgaiyan; Igor Elman; Mark S Gold
Journal:  Mol Neurobiol       Date:  2021-03-08       Impact factor: 5.590
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.